DESIPRAMINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Desipramine Hydrochloride patents expire, and when can generic versions of Desipramine Hydrochloride launch?
Desipramine Hydrochloride is a drug marketed by Actavis Totowa, Alembic, Amneal Pharms Co, Ani Pharms, Chartwell Rx, Heritage, Novast Labs, and Usl Pharma. and is included in sixteen NDAs.
The generic ingredient in DESIPRAMINE HYDROCHLORIDE is desipramine hydrochloride. There are nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the desipramine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Desipramine Hydrochloride
A generic version of DESIPRAMINE HYDROCHLORIDE was approved as desipramine hydrochloride by ACTAVIS TOTOWA on June 5th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DESIPRAMINE HYDROCHLORIDE?
- What are the global sales for DESIPRAMINE HYDROCHLORIDE?
- What is Average Wholesale Price for DESIPRAMINE HYDROCHLORIDE?
Summary for DESIPRAMINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 16 |
| Finished Product Suppliers / Packagers: | 9 |
| Raw Ingredient (Bulk) Api Vendors: | 89 |
| Clinical Trials: | 61 |
| Patent Applications: | 1,509 |
| DailyMed Link: | DESIPRAMINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for DESIPRAMINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| King's College London | Phase 3 |
| NHS Lothian | Phase 3 |
| University College, London | Phase 3 |
Pharmacology for DESIPRAMINE HYDROCHLORIDE
| Drug Class | Tricyclic Antidepressant |
Medical Subject Heading (MeSH) Categories for DESIPRAMINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for DESIPRAMINE HYDROCHLORIDE
US Patents and Regulatory Information for DESIPRAMINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heritage | DESIPRAMINE HYDROCHLORIDE | desipramine hydrochloride | TABLET;ORAL | 207433-006 | May 5, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Chartwell Rx | DESIPRAMINE HYDROCHLORIDE | desipramine hydrochloride | TABLET;ORAL | 072103-004 | May 24, 1988 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Usl Pharma | DESIPRAMINE HYDROCHLORIDE | desipramine hydrochloride | TABLET;ORAL | 071865-001 | Sep 9, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
